Pharmaceutical Research and Manufacturers of America IEC
A - OTH
$11.54M
Total received
273
Donations
61
Unique contributors
$42.3K
Avg donation
Years active: 2025, 2024, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016, 2015, 2014, 2013, 2012, 2011, 2010, 2009
Top Contributions
| Date | Contributor | Type | Amount |
|---|---|---|---|
| Mar 5, 2009 | Johnson & Johnson Services Inc. | OTH | $69,000 |
| Mar 5, 2009 | Lilly & Company, Eli | OTH | $69,000 |
| Mar 5, 2009 | Merck & Co. | OTH | $69,000 |
| Mar 5, 2009 | Novartis Pharmaceuticals Corporation | OTH | $69,000 |
| Mar 5, 2009 | GlaxoSmithKline | OTH | $69,000 |
| Mar 5, 2009 | Johnson & Johnson Services Inc. | OTH | $69,000 |
| Mar 5, 2009 | Lilly & Company, Eli | OTH | $69,000 |
| Mar 5, 2009 | Merck & Co. | OTH | $69,000 |
| Mar 5, 2009 | Novartis Pharmaceuticals Corporation | OTH | $69,000 |
| Jun 10, 2009 | Abbott Laboratories | OTH | $69,000 |
| Mar 5, 2009 | Amgen, Inc. | OTH | $69,000 |
| Mar 5, 2009 | Bristol Myers Squibb Company | OTH | $69,000 |
| Mar 5, 2009 | Amgen, Inc. | OTH | $69,000 |
| Mar 5, 2009 | Bristol Myers Squibb Company | OTH | $69,000 |
| Mar 5, 2009 | GlaxoSmithKline | OTH | $69,000 |
| May 14, 2025 | GSK | OTH | $65,200 |
| Jun 24, 2025 | Merck & Co. Inc | OTH | $65,200 |
| Apr 14, 2025 | Lundbeck Inc. | OTH | $65,200 |
| May 14, 2025 | UCB, Inc. | OTH | $65,200 |
| Apr 14, 2025 | Amgen, Inc. | OTH | $65,200 |
| Apr 14, 2025 | Bayer US, LLC(Devon Anderson) | OTH | $65,200 |
| Mar 11, 2025 | Genentech, Inc. | OTH | $65,200 |
| Jun 24, 2025 | Bristol-Myers Squibb Company | OTH | $65,200 |
| Mar 11, 2025 | Eli Lilly and Company | OTH | $65,200 |
| Mar 11, 2025 | Sanofi-Aventis | OTH | $65,200 |
| May 14, 2025 | Takeda Pharmaceuticals America Inc. | OTH | $65,200 |
| May 14, 2025 | Otsuka | OTH | $65,200 |
| Mar 11, 2025 | Novartis Pharmaceuticals Corporation | OTH | $65,200 |
| May 14, 2025 | Neurocrine Biosciences | OTH | $65,200 |
| Oct 12, 2018 | Boehringer Ingelheim Pharmaceuticals | OTH | $62,700 |
| Apr 19, 2018 | Astellas Pharma US, Inc. | OTH | $62,700 |
| Mar 23, 2018 | Abbvie | OTH | $62,700 |
| Feb 7, 2018 | Bristol Myers Squibb Company | OTH | $62,700 |
| Mar 23, 2018 | Celgene Corporation | OTH | $62,700 |
| Mar 23, 2018 | Daiichi Sankyo, Inc. | OTH | $62,700 |
| Mar 23, 2018 | Eli Lilly and Company | OTH | $62,700 |
| Mar 23, 2018 | Merck & Co. | OTH | $62,700 |
| Feb 7, 2018 | Novartis Pharmaceuticals Corporation | OTH | $62,700 |
| Mar 23, 2018 | Takeda Pharmaceuticals | OTH | $62,700 |
| Mar 23, 2018 | Abbvie | OTH | $62,700 |
| Jun 21, 2018 | Amgen, Inc. | OTH | $62,700 |
| Mar 23, 2018 | Takeda Pharmaceuticals | OTH | $62,700 |
| Apr 19, 2018 | Sanofi-Aventis | OTH | $62,700 |
| Feb 7, 2018 | Novartis Pharmaceuticals Corporation | OTH | $62,700 |
| Mar 23, 2018 | Merck & Co. | OTH | $62,700 |
| Mar 23, 2018 | Eli Lilly and Company | OTH | $62,700 |
| Mar 23, 2018 | Daiichi Sankyo, Inc. | OTH | $62,700 |
| Mar 23, 2018 | Celgene Corporation | OTH | $62,700 |
| Jun 21, 2018 | Amgen, Inc. | OTH | $62,700 |
| Feb 7, 2018 | Bristol Myers Squibb Company | OTH | $62,700 |
| May 6, 2019 | Sanofi-Aventis | OTH | $62,200 |
| Jan 25, 2019 | Novartis Pharmaceuticals Corporation | OTH | $62,200 |
| Jan 25, 2019 | Eli Lilly and Company | OTH | $62,200 |
| Jun 27, 2019 | Bristol Myers Squibb Company | OTH | $62,200 |
| Jan 25, 2019 | Bayer HealthCare LLC | OTH | $62,200 |
| Jan 25, 2019 | Astellas Pharma US, Inc. | OTH | $62,200 |
| Feb 27, 2019 | Amgen, Inc. | OTH | $62,200 |
| Feb 27, 2019 | Lundbeck Inc. | OTH | $62,200 |
| May 6, 2019 | Takeda Pharmaceuticals | OTH | $62,200 |
| May 6, 2019 | Genetech, Inc. | OTH | $62,200 |
| Apr 15, 2024 | Genentech, Inc. | OTH | $55,900 |
| Feb 14, 2024 | Eli Lilly and Company | OTH | $55,900 |
| Aug 1, 2024 | Bristol-Myers Squibb Company | OTH | $55,900 |
| Apr 15, 2024 | Bayer US, LLC(Alisa Reinhardt) | OTH | $55,900 |
| Feb 14, 2024 | Astellas Pharma US, Inc. | OTH | $55,900 |
| Apr 15, 2024 | Amgen, Inc. | OTH | $55,900 |
| Feb 14, 2024 | Lundbeck Inc. | OTH | $55,900 |
| May 23, 2024 | Merck & Co. Inc | OTH | $55,900 |
| Jun 27, 2024 | Neurocrine Biosciences | OTH | $55,900 |
| Apr 15, 2024 | Novartis Pharmaceuticals Corporation | OTH | $55,900 |
| Jun 27, 2024 | Otsuka | OTH | $55,900 |
| Apr 15, 2024 | Sanofi-Aventis | OTH | $55,900 |
| May 23, 2024 | Takeda Pharmaceuticals America Inc. | OTH | $55,900 |
| Jun 27, 2024 | UCB, Inc. | OTH | $55,900 |
| Apr 15, 2024 | GSK | OTH | $55,900 |
| Feb 26, 2015 | Amgen, Inc. | OTH | $54,000 |
| Mar 1, 2010 | Amgen, Inc. | OTH | $54,000 |
| Mar 1, 2010 | Astellas Pharma US, Inc. | OTH | $54,000 |
| Feb 26, 2015 | Actavis | OTH | $54,000 |
| Feb 26, 2015 | Abbvie | OTH | $54,000 |
| Aug 1, 2012 | Bristol Myers Squibb Company | OTH | $54,000 |
| Mar 16, 2012 | Johnson & Johnson Services Inc. | OTH | $54,000 |
| Mar 1, 2010 | GlaxoSmithKline | OTH | $54,000 |
| Mar 1, 2010 | Johnson & Johnson Services Inc. | OTH | $54,000 |
| Mar 16, 2012 | Daiichi Sankyo | OTH | $54,000 |
| Mar 1, 2010 | Lilly & Company, Eli | OTH | $54,000 |
| Mar 16, 2012 | Astellas Pharma US, Inc. | OTH | $54,000 |
| Mar 1, 2010 | Merck & Co. | OTH | $54,000 |
| Mar 1, 2010 | Pfizer Inc. | OTH | $54,000 |
| Mar 29, 2013 | Abbvie | OTH | $54,000 |
| Mar 29, 2013 | Daiichi Sankyo | OTH | $54,000 |
| Mar 29, 2013 | Celgene | OTH | $54,000 |
| Mar 16, 2012 | Novartis Pharmaceuticals Corporation | OTH | $54,000 |
| Feb 26, 2015 | Merck & Co. | OTH | $54,000 |
| Feb 26, 2015 | Eli Lilly and Company | OTH | $54,000 |
| Mar 16, 2012 | Merck & Co. | OTH | $54,000 |
| Feb 26, 2015 | Daiichi Sankyo, Inc. | OTH | $54,000 |
| Feb 26, 2015 | Celgene Corporation | OTH | $54,000 |
| Feb 26, 2015 | Bristol-Myers Squibb Company | OTH | $54,000 |
| Feb 26, 2015 | Astellas Pharma US, Inc. | OTH | $54,000 |
| Mar 1, 2010 | Takeda Pharmaceuticals | OTH | $54,000 |
| Mar 29, 2013 | Takeda Pharmaceuticals | OTH | $54,000 |
| Mar 29, 2013 | Amgen, Inc. | OTH | $54,000 |
| Mar 16, 2012 | Abbott Laboratories | OTH | $54,000 |
| Feb 26, 2015 | Takeda Pharmaceuticals | OTH | $54,000 |
| May 3, 2012 | Lilly & Company, Eli | OTH | $54,000 |
| Mar 29, 2013 | Astellas Pharma US, Inc. | OTH | $54,000 |
| Mar 29, 2013 | Merck & Co. | OTH | $54,000 |
| Mar 29, 2013 | Johnson & Johnson Services Inc. | OTH | $54,000 |
| Mar 29, 2013 | Lilly & Company, Eli | OTH | $54,000 |
| Mar 16, 2012 | Takeda Pharmaceuticals | OTH | $54,000 |
| Feb 22, 2017 | Novartis Pharmaceuticals Corporation | OTH | $52,700 |
| Feb 22, 2017 | Celgene Corporation | OTH | $52,700 |
| Feb 22, 2017 | Abbvie | OTH | $52,700 |
| Feb 22, 2017 | Mallinckrodt Pharmaceuticals | OTH | $52,700 |
| Feb 22, 2017 | Boehringer Ingelheim Pharmaceuticals | OTH | $52,700 |
| Feb 22, 2017 | Johnson & Johnson | OTH | $52,700 |
| Feb 22, 2017 | Eli Lilly and Company | OTH | $52,700 |
| Feb 22, 2017 | Sanofi-Aventis | OTH | $52,700 |
| Feb 22, 2017 | Takeda Pharmaceuticals | OTH | $52,700 |
| Feb 22, 2017 | Horizon Pharma | OTH | $52,700 |
| Feb 26, 2014 | Eli Lilly and Company | OTH | $50,000 |
| Feb 20, 2020 | UCB Pharma, Inc. | OTH | $50,000 |
| Apr 3, 2020 | Abbvie | OTH | $50,000 |
| Feb 20, 2020 | Amgen, Inc. | OTH | $50,000 |
| Apr 3, 2020 | Astellas Pharma US, Inc. | OTH | $50,000 |
| Feb 20, 2020 | Bayer Corporation | OTH | $50,000 |
| Feb 20, 2020 | Genetech, Inc. | OTH | $50,000 |
| Apr 3, 2020 | Lundbeck Inc. | OTH | $50,000 |
| Feb 20, 2020 | Novartis Pharmaceuticals Corporation | OTH | $50,000 |
| Apr 3, 2020 | Sanofi-Aventis | OTH | $50,000 |
| Feb 20, 2020 | Takeda Pharmaceuticals America Inc. | OTH | $50,000 |
| Feb 26, 2014 | Abbvie | OTH | $50,000 |
| Feb 26, 2014 | Amgen, Inc. | OTH | $50,000 |
| Feb 26, 2014 | Bristol-Myers Squibb Company | OTH | $50,000 |
| Feb 26, 2014 | Celgene Corporation | OTH | $50,000 |
| Feb 26, 2014 | Daiichi Sankyo, Inc. | OTH | $50,000 |
| Feb 26, 2014 | Johnson & Johnson Services Inc. | OTH | $50,000 |
| Feb 26, 2014 | Merck & Co. | OTH | $50,000 |
| Feb 26, 2014 | Novartis Pharmaceuticals Corporation | OTH | $50,000 |
| Feb 26, 2014 | Takeda Pharmaceuticals | OTH | $50,000 |
| Mar 5, 2021 | Astellas Pharma US, Inc. | OTH | $50,000 |
| Mar 5, 2021 | Eisai, Inc. | OTH | $50,000 |
| Mar 5, 2021 | Eli Lilly and Company | OTH | $50,000 |
| Mar 5, 2021 | Lundbeck Inc. | OTH | $50,000 |
| Mar 5, 2021 | Merck & Co. Inc | OTH | $50,000 |
| Mar 5, 2021 | Sanofi-Aventis | OTH | $50,000 |
| Mar 5, 2021 | UCB Pharma, Inc. | OTH | $50,000 |
| Apr 29, 2021 | Bristol-Myers Squibb Company | OTH | $50,000 |
| Apr 29, 2021 | Genetech, Inc. | OTH | $50,000 |
| Jun 22, 2021 | Novartis Pharmaceuticals Corporation | OTH | $50,000 |
| Jun 22, 2021 | Takeda Pharmaceuticals America Inc. | OTH | $50,000 |
| Mar 15, 2022 | Astellas Pharma US, Inc. | OTH | $50,000 |
| Mar 15, 2022 | Bayer Corporation | OTH | $50,000 |
| Mar 15, 2022 | Bristol-Myers Squibb Company | OTH | $50,000 |
| Mar 15, 2022 | Eisai, Inc. | OTH | $50,000 |
| Mar 15, 2022 | Eli Lilly and Company | OTH | $50,000 |
| Mar 15, 2022 | Genetech, Inc. | OTH | $50,000 |
| Mar 15, 2022 | Novartis Pharmaceuticals Corporation | OTH | $50,000 |
| Mar 15, 2022 | Takeda Pharmaceuticals America Inc. | OTH | $50,000 |
| Mar 15, 2022 | UCB Pharma, Inc. | OTH | $50,000 |
| May 4, 2023 | Amgen, Inc. | OTH | $50,000 |
| Feb 16, 2023 | Astellas Pharma US, Inc. | OTH | $50,000 |
| Feb 16, 2023 | Bayer US, LLC(Alisa Reinhardt) | OTH | $50,000 |
| May 4, 2023 | Bristol-Myers Squibb Company | OTH | $50,000 |
| Feb 16, 2023 | Eli Lilly and Company | OTH | $50,000 |
| May 4, 2023 | Genentech, Inc. | OTH | $50,000 |
| Feb 16, 2023 | GSK | OTH | $50,000 |
| Feb 16, 2023 | Lundbeck Inc. | OTH | $50,000 |
| May 4, 2023 | Merck & Co. Inc | OTH | $50,000 |
| Feb 16, 2023 | Novartis Pharmaceuticals Corporation | OTH | $50,000 |
| Feb 16, 2023 | Sanofi-Aventis | OTH | $50,000 |
| May 4, 2023 | Takeda Pharmaceuticals America Inc. | OTH | $50,000 |
| May 4, 2023 | UCB, Inc. | OTH | $50,000 |
| Jul 18, 2022 | Amgen, Inc. | OTH | $50,000 |
| Aug 4, 2022 | Merck & Co. Inc | OTH | $50,000 |
| Feb 20, 2020 | Eli Lilly and Company | OTH | $50,000 |
| May 10, 2022 | Abbvie | OTH | $50,000 |
| May 10, 2022 | GlaxoSmithKline | OTH | $50,000 |
| May 10, 2022 | Lundbeck Inc. | OTH | $50,000 |
| May 10, 2022 | Sanofi-Aventis | OTH | $50,000 |
| Mar 28, 2011 | Abbott Laboratories | OTH | $50,000 |
| Mar 28, 2011 | Astellas Pharma US, Inc. | OTH | $50,000 |
| Mar 28, 2011 | Bristol Myers Squibb Company | OTH | $50,000 |
| Mar 28, 2011 | Daiichi Sankyo | OTH | $50,000 |
| Mar 28, 2011 | Eisai, Inc. | OTH | $50,000 |
| Mar 28, 2011 | GlaxoSmithKline | OTH | $50,000 |
| Mar 28, 2011 | Johnson & Johnson Services Inc. | OTH | $50,000 |
| Mar 28, 2011 | Lilly & Company, Eli | OTH | $50,000 |
| Mar 28, 2011 | Merck & Co. | OTH | $50,000 |
| Mar 28, 2011 | Takeda Pharmaceuticals | OTH | $50,000 |
| Nov 2, 2021 | Abbvie | OTH | $50,000 |
| Aug 10, 2021 | Amgen, Inc. | OTH | $50,000 |
| Aug 10, 2021 | Bayer Corporation | OTH | $50,000 |
| Mar 17, 2016 | Abbvie | OTH | $39,824 |
| Mar 17, 2016 | Celgene Corporation | OTH | $39,818 |
| Mar 17, 2016 | Bristol-Myers Squibb Company | OTH | $39,818 |
| Mar 17, 2016 | Takeda Pharmaceuticals | OTH | $39,818 |
| Mar 17, 2016 | Novartis Pharmaceuticals Corporation | OTH | $39,818 |
| Mar 17, 2016 | Mallinckrodt Pharmaceuticals | OTH | $39,818 |
| Mar 17, 2016 | EMD Serono, Inc. | OTH | $39,818 |
| Mar 17, 2016 | Eli Lilly and Company | OTH | $39,818 |
| Mar 17, 2016 | Daiichi Sankyo, Inc. | OTH | $39,818 |
| Mar 17, 2016 | Amgen, Inc. | OTH | $39,818 |
| Mar 17, 2016 | Astellas Pharma US, Inc. | OTH | $39,818 |
| Apr 2, 2010 | Abbott Laboratories | OTH | $20,000 |
| Apr 2, 2010 | Bristol Myers Squibb Company | OTH | $20,000 |
| Apr 2, 2010 | Abbott Laboratories | OTH | $20,000 |
| Apr 2, 2010 | Bristol Myers Squibb Company | OTH | $20,000 |
| Jun 30, 2020 | Merck & Co. | OTH | $13,300 |
| Jun 30, 2020 | Ipsen Biopharmaceuticals, Inc. | OTH | $13,300 |
| Jun 30, 2020 | Bristol Myers Squibb Company | OTH | $13,300 |
| Jun 30, 2020 | Alkermes, Inc. | OTH | $13,300 |
| Mar 16, 2012 | EMD Serono, Inc. | OTH | $3,999 |
| Mar 5, 2009 | Takeda Pharmaceuticals | OTH | $3,999 |
| Apr 18, 2014 | Eisai, Inc. | OTH | $3,999 |
| Mar 29, 2013 | EMD Serono, Inc. | OTH | $3,999 |
| Mar 1, 2010 | Purdue Pharma, L.P. | OTH | $3,999 |
| Feb 26, 2014 | Boehringer Ingelheim Pharmaceuticals | OTH | $3,999 |
| Mar 5, 2009 | Takeda Pharmaceuticals | OTH | $3,999 |
| Mar 5, 2009 | Sigma Tau Pharmaceuticals | OTH | $3,999 |
| Mar 1, 2010 | Sigma Tau Pharmaceuticals | OTH | $3,999 |
| Mar 5, 2009 | Sigma Tau Pharmaceuticals | OTH | $3,999 |
| Mar 1, 2010 | Daiichi Sankyo | OTH | $3,999 |
| Mar 1, 2010 | EMD Serono, Inc. | OTH | $3,999 |
| Mar 1, 2010 | Endo Pharmaceuticals | OTH | $3,999 |
| Mar 5, 2009 | Endo Pharmaceuticals | OTH | $3,999 |
| Mar 5, 2009 | Endo Pharmaceuticals | OTH | $3,999 |
| Mar 5, 2009 | Hoffmann - La Roche | OTH | $3,999 |
| Mar 5, 2009 | Hoffmann - La Roche | OTH | $3,999 |
| Mar 17, 2016 | Novo Nordisk, Inc. | OTH | $2,999 |
| Mar 17, 2016 | ORexigen | OTH | $2,999 |
| Mar 17, 2016 | Purdue Pharma, L.P. | OTH | $2,999 |
| Mar 17, 2016 | Allergan | OTH | $2,999 |
| Feb 22, 2017 | Allergan | OTH | $2,699 |
| Apr 19, 2018 | Allergan | OTH | $2,699 |
| Feb 20, 2020 | Allergan | OTH | $2,199 |
| Feb 20, 2020 | Incyte Corporation | OTH | $2,199 |
| Feb 20, 2020 | Sunovian, Inc. | OTH | $2,199 |
| Feb 27, 2019 | Alexion Pharmaceuticals, Inc | OTH | $2,199 |
| Jun 27, 2019 | Sunovian, Inc. | OTH | $2,199 |
| May 6, 2019 | Allergan | OTH | $2,199 |
| May 6, 2019 | Boehringer Ingelheim Pharmaceuticals | OTH | $2,199 |
| May 6, 2019 | Ipsen Biopharmaceuticals, Inc. | OTH | $2,199 |
| Jan 25, 2019 | UCB Pharma, Inc. | OTH | $2,199 |
| Jul 18, 2022 | Valenti, JohnIpsen Biopharmaceuticals | IND | $1,899 |
| Apr 29, 2021 | Alkermes, Inc. | OTH | $1,899 |
| Apr 29, 2021 | Ipsen Biopharmaceuticals, Inc. | OTH | $1,899 |
| Apr 29, 2021 | Sunovian, Inc. | OTH | $1,899 |
| Mar 15, 2022 | Sage Therapeutics | OTH | $1,899 |
| Apr 29, 2013 | Logue 2012 Officeholder Committee, Assemblyman Dan | COM | $1,500 |
| May 4, 2023 | Alkermes, Inc. | OTH | $899 |
| Sep 5, 2024 | Biogen Inc. | OTH | $899 |
| May 4, 2023 | Sunovian Pharmaceuticals, Inc. | OTH | $899 |
| Feb 16, 2023 | Ipsen Biopharmaceuticals, Inc. | OTH | $899 |
| May 4, 2023 | EMD Serono, Inc. | OTH | $899 |
| Feb 16, 2023 | Daiichi Sankyo, Inc. | OTH | $899 |
| Feb 14, 2024 | Ispen Biopharmaceuticals | OTH | $899 |
| Apr 15, 2024 | Genmab | OTH | $899 |
| Apr 15, 2024 | Alkermes, Inc. | OTH | $899 |
| May 7, 2009 | Franchise Tax Board | OTH | $591.57 |
| May 7, 2009 | Franchise Tax Board | OTH | $591.57 |
| Mar 11, 2025 | Eisai, Inc. | OTH | $199 |
| Apr 14, 2025 | Alkermes, Inc. | OTH | $199 |
| Jun 24, 2025 | Biogen Inc. | OTH | $199 |
| May 14, 2025 | Genmab | OTH | $199 |
| Mar 11, 2025 | Ispen Biopharmaceuticals | OTH | $199 |
| Jan 1, 2009 | Wells Fargo | OTH | $35.4 |
| Jan 1, 2009 | Wells Fargo | OTH | $35.4 |
| Feb 27, 2009 | Wells Fargo | OTH | $33.04 |
| Feb 27, 2009 | Wells Fargo | OTH | $33.04 |
| Mar 31, 2009 | Wells Fargo | OTH | $4.72 |
| Mar 31, 2009 | Wells Fargo | OTH | $4.72 |